13G Filing: Paulson & Co and Synergy Pharmaceuticals Inc. (SGYP)

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP): John Paulson’s Paulson & Co filed an amended 13D.

You can check out Paulson & Co’s latest holdings and filings here.

Please follow Paulson & Co (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Paulson & Co or update its stock holdings.

John Paulson
John Paulson
Paulson & Co

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Paulson Co. Inc 4,400,000 0 4,400,000 0 4,400,000 1.78%
John Paulson
John Paulson
Paulson & Co

Page 1 of 5 – SEC Filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
SCHEDULE 13G
(RULE 13d – 102)
Under the Securities Exchange Act of 1934
(Amendment No. 2)*
Synergy Pharmaceuticals Inc.
(Name of Issuer)
Common Stock, par value $0.001 per share
(Title of Class of Securities)
871639308
(CUSIP Number)
November 30, 2017
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
[x] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
Follow Synergy Pharmaceuticals Inc. (NASDAQ:SGYP)